Drug delivery technologies, Generics
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
564
NCT04818320
Favipiravir in High-risk COVID-19 Patients
Phase: Phase 3
Role: Collaborator
Start: Feb 16, 2021
Completion: Jul 13, 2021
NCT07161960
Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE)
Phase: N/A
Start: Jul 1, 2025
Completion: Nov 1, 2027
Loading map...